NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.02% | -3.82% | -9.42% | 67.83% | -144.24% |
| Total Depreciation and Amortization | -3.89% | -22.47% | -31.52% | -15.80% | -3.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,153.08% | -18.25% | -23.50% | 20.00% | -53.86% |
| Change in Net Operating Assets | 86.10% | -578.68% | -20.07% | -61.04% | 173.02% |
| Cash from Operations | 27.30% | -74.95% | -21.86% | 72.40% | -74.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 652.77% | -78.34% | -31.00% | 131.44% | -47.01% |
| Cash from Investing | 652.77% | -78.34% | -31.00% | 131.44% | -47.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.24% | -94.20% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.24% | -93.85% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.86% | -157.96% | 667.19% | 114.36% | -187.03% |